gut microbes glp-1 activity link Science Page A surprising role for enteroendocrine

That is worth repeating

If weight loss is still continuing, your provider may recommend waiting until your weight has stabilized

Wegovy (Semaglutide): A once-weekly injection FDA-approved for the treatment of obesity and the risk of cardiovascular events associated with obesity

Purpose-built for physicians Human, exendin-based GLP-1 receptor agonists similarly reduce CV, renal risk in diabetes A pooled study assessing trials of eight GLP-1 receptor agonists showed all reduce risk for a combined endpoint of major adverse cardiovascular events, regardless of structural homology to human GLP-1, as well as individual CV components

In addition, combination therapy with ixekizumab (Taltz) is in Phase 3 trials for adults with plaque psoriasis (PSO) or psoriatic arthritis (PsA)